Expert Panel on Cervical Cancer Screening

Meeting Overview

The purpose of this meeting is to inform the development of a joint committee opinion for ACOG and ASCCP on alternative cervical cancer screening strategies, such as visual inspection with acetic acid (VIA) or primary Human papillomavirus testing. The panel will review the World Health Organization's (WHO) guidelines and available literature on cervical cancer and identify alternative screening strategies would be considered acceptable and reimbursable screening in the U.S. territories and freely associated states of the U.S. Affiliated Pacific Islands (including Puerto Rico, U.S. Virgin Islands, Guam, Federated States of Micronesia, Republic of the Marshall Islands, Republic of Palau, American Samoa and Commonwealth of the Northern Marianas) and could be considered for inclusion in the Centers for Disease Control and Prevention's (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and Health and Human Services' (HHS) Office of Population Affairs' (OPA) Title X family planning programs. The intent of this expert panel is to examine strategies for improving cervical cancer screening in the U.S. Territories and Pacific Island Jurisdictions, where communities have limited access to screening, diagnostic and treatment services.

Objectives:

  • Understand current population cervical cancer screening and needs of the U.S. Territories and Pacific Islands Jurisdictions
  • Review and discuss the World Health Organization's (WHO) guidelines and available literature on cervical cancer
  • Review program policies of the Centers for Disease Control and Prevention's (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and Health and Human Services' (HHS) Office of Population Affairs' (OPA) Title X family planning program